CD274 and neoplasm: Therefore, coupled with the tumor‐specific promoter to control CRISPR/Cas9 expression is also an effective approach to avoid nonspecific editing, which could be adopted in future studies to further improve the security of our proposed paradigm for PD‐L1 genome editing.